Skip to main content
Clinical Trials/NCT04473404
NCT04473404
Completed
Not Applicable

Evaluation of the Effect of an Oral Probiotic on Oral Bacteria and Malodor

Dose Biosystems Inc.1 site in 1 country48 target enrollmentJuly 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oral Bacteria
Sponsor
Dose Biosystems Inc.
Enrollment
48
Locations
1
Primary Endpoint
Oral bacteria levels in saliva and plaque
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effects of consuming a probiotic on salivary, plaque, and tongue bacteria, as well as oral malodor (bad breath). Healthy volunteers will consume a probiotic powder, or a placebo powder, that is dissolved in water for 4 weeks.

Detailed Description

The oral cavity houses one of the most diverse microbiota in the human body. There are nearly 800 unique oral bacterial species identified with more species expected to be added with further sampling and identification. As with microbiota of other sites in the body, a balanced oral microbiota is essential to maintaining the health of the human host. Streptococcus salivarius is a pioneer species that colonizes the human oral cavity from birth, and remains a predominant member of the commensal microbiota throughout life. The commensal microbiota provides protection against pathogenic species associated with conditions such as dental caries, periodontal disease, and oral malodor (halitosis). This randomized, double-blind, placebo-controlled study is conducted to investigate the effect of a Streptococcus salivarius DB-B5 strain on oral bacteria levels and halitosis. Doses of 2 billion and 10 billion colony forming units (CFU) per day are tested.

Registry
clinicaltrials.gov
Start Date
July 20, 2020
End Date
August 26, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults, 18 to 65 years of age and in good general health and good oral health (no active or uncontrolled diseases or conditions).
  • Presence of at least 20 natural teeth, excluding third molars.
  • Read and sign the Research Subject Information and Consent Form.
  • Have an OralChroma reading ≥ 125 ppb hydrogen sulfide (H2S) gas, volatile sulfur compound (VSC) (at least 8-12 hours after eating or drinking or oral hygiene) at Baseline.
  • Willingness to use the assigned products according to instructions, attend scheduled appointments, and likelihood of completing the study.
  • Males and females with reproductive potential agree to use medically acceptable contraception, as determined by the investigator, for the duration of the study and 30 days after study completion and attest to having used it for three months prior to screening.
  • Females of child-bearing potential agree to submit to a urine pregnancy test at screening and at the end of the study.

Exclusion Criteria

  • Fewer than 20 natural, uncrowned teeth.
  • Active or chronic dental disease.
  • Self-reported dry mouth (xerostomia) by questionnaire.
  • Have had or used any of the following in the past three months: antibiotic treatment, a dental cleaning, mouthrinse.
  • Regular use of probiotic supplements or regular consumption of probiotic rich foods such as yoghurt or kefir in the past month.
  • Require antibiotic prophylaxis for dental or any treatment.
  • Removable or fixed dental appliances (no implants; crowns allowed if subject has at least 20 uncrowned teeth)
  • Pregnant or planning to become pregnant during the study period, or breastfeeding.
  • Uses tobacco products (including smokeless, vaping, and nicotine chewing gums/sprays/lozenges).
  • Chronic or acute illness such as heart disease, diabetes, cancer, autoimmune condition or HIV that could impact outcome of the study in the opinion of the investigator.

Outcomes

Primary Outcomes

Oral bacteria levels in saliva and plaque

Time Frame: 4 weeks

Change in the levels of the following bacteria in the saliva, and in samples of supra- and subgingival plaque: Streptococcus salivarius (total), Streptococcus salivarius DB-B5 (probiotic strain), Streptococcus mutans and Porphyromonas gingivalis.

Oral bacteria levels on the tongue

Time Frame: 4 weeks

Change in the levels of the following bacteria in back-of-tongue samples: Tannerella forsythia, Prevotella (total), Streptococcus salivarius (total) and Streptococcus salivarius DB-B5 (probiotic strain).

Oral malodor

Time Frame: 4 weeks

Change in OralChroma malodor readings.

Study Sites (1)

Loading locations...

Similar Trials